(Q81099042)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17805332%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

title

The immunomodulatory drug Leflunomide inhibits cell cycle progression of B-CLL cells (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17805332%20AND%20SRC:MED&resulttype=core&format=json

B-cell chronic lymphocytic leukemia

5 January 2020

main subject

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17805332%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

author name string

Oelsner M

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17805332%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

Bogner C

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17805332%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

Peschel C

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17805332%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

Decker T

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17805332%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

publication date

6 September 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17805332%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17805332%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

volume

22

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17805332%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17805332%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

page(s)

635-638

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17805332%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/sj.leu.2404922

5 January 2020

exact match

0 references

cites work

The immunosuppressive metabolite of leflunomide is a potent inhibitor of human dihydroorotate dehydrogenase

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404922

7 January 2021

In vitro and in vivo antitumor activity of a novel immunomodulatory drug, leflunomide: mechanisms of action

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404922

7 January 2021

Inhibition of the proteasome induces cell cycle arrest and apoptosis in mantle cell lymphoma cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404922

7 January 2021

Constitutively activated phosphatidylinositol-3 kinase (PI-3K) is involved in the defect of apoptosis in B-CLL: association with protein kinase Cdelta.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404922

7 January 2021

Cell cycle progression of chronic lymphocytic leukemia cells is controlled by cyclin D2, cyclin D3, cyclin-dependent kinase (cdk) 4 and the cdk inhibitor p27

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404922

7 January 2021

Inhibition of Protein Tyrosine Phosphorylation in T Cells by a Novel Immunosuppressive Agent, Leflunomide

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404922

7 January 2021